Related references
Note: Only part of the references are listed.Monitoring changes in smoking and quitting behaviours among Australians with and without mental illness over 15 years
Elizabeth M. Greenhalgh et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH (2022)
Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking
M. J. Jaen-Moreno et al.
EUROPEAN PSYCHIATRY (2021)
A 5-Factor Framework for Assessing Tobacco Use Disorder
Matthew Bucklin
TOBACCO USE INSIGHTS (2021)
Individual-level behavioural smoking cessation interventions tailored for disadvantaged socioeconomic position: a systematic review and meta-regression
Loren Kock et al.
Lancet Public Health (2019)
Smoking cessation for people with severe mental illness (SCIMITAR plus ): a pragmatic randomised controlled trial
Simon Gilbody et al.
LANCET PSYCHIATRY (2019)
The Methodological Quality and Effectiveness of Technology-Based Smoking Cessation Interventions for Disadvantaged Groups: A Systematic Review and Meta-analysis
Veronica C. Boland et al.
NICOTINE & TOBACCO RESEARCH (2018)
Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity
Faith Dickerson et al.
PSYCHIATRIC SERVICES (2018)
Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients
Julia Margaret Lappin et al.
SCHIZOPHRENIA RESEARCH (2018)
A Systematic Review of Psychosocial Barriers and Facilitators to Smoking Cessation in People Living With Schizophrenia
Alistair Lum et al.
FRONTIERS IN PSYCHIATRY (2018)
Randomised controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders: Outcomes to 36months
Amanda L. Baker et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2018)
Long-term abstinence and predictors of tobacco treatment uptake among hospitalized smokers with serious mental illness enrolled in a smoking cessation trial
Erin S. Rogers et al.
JOURNAL OF BEHAVIORAL MEDICINE (2017)
Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis
Carsten Hjorthoj et al.
LANCET PSYCHIATRY (2017)
Self-Reported Reasons for Smoking: Predicting Abstinence and Implications for Smoking Cessation Treatments Among Those With a Psychotic Disorder
Vanessa Clark et al.
JOURNAL OF DUAL DIAGNOSIS (2017)
Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial
Anne N. Thorndike et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
Robert M. Anthenelli et al.
LANCET (2016)
Sex/gender differences in smoking cessation: A review
Philip H. Smith et al.
PREVENTIVE MEDICINE (2016)
It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline
Maria P. Garcia-Portilla et al.
SCHIZOPHRENIA RESEARCH (2016)
Cigarette Smoking and Interest in Quitting Among Overweight and Obese Adults With Serious Mental Illness Enrolled in a Fitness Intervention
Kelly A. Aschbrenner et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2015)
Randomized Controlled Trial of a Healthy Lifestyle Intervention Among Smokers With Psychotic Disorders
Amanda L. Baker et al.
NICOTINE & TOBACCO RESEARCH (2015)
Psychosis, Socioeconomic Disadvantage, and Health Service Use in South Australia: Findings from the Second Australian National Survey of Psychosis
Shaun Sweeney et al.
FRONTIERS IN PUBLIC HEALTH (2015)
Bespoke smoking cessation for people with severe mental ill health (SCIMITAR): a pilot randomised controlled trial
Simon Gilbody et al.
LANCET PSYCHIATRY (2015)
Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder A Randomized Clinical Trial
A. Eden Evins et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Varenicline for Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study
K. N. Roy Chengappa et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Gender differences in characteristics and outcomes of smokers diagnosed with psychosis participating in a smoking cessation intervention
Sacha L. Filia et al.
PSYCHIATRY RESEARCH (2014)
Probability and predictors of relapse to smoking: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
Olaya Garcia-Rodriguez et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia
Corinne Cather et al.
JOURNAL OF DUAL DIAGNOSIS (2013)
Effects of Tobacco Smoking on Neuropsychological Function in Schizophrenia in Comparison to Other Psychiatric Disorders and Non-psychiatric Controls
Dominique Morisano et al.
AMERICAN JOURNAL ON ADDICTIONS (2013)
Interventions for smoking cessation and reduction in individuals with schizophrenia
Daniel T. Tsoi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder
Jill M. Williams et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Smoking and mental illness: a population study in South Australia
Jacqueline A. Bowden et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2011)
Smoking Characteristics of Adults With Selected Lifetime Mental Illnesses: Results From the 2007 National Health Interview Survey
Annette K. McClave et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2010)
Cigarette smoking and psychosis: naturalistic follow up 4 years after an intervention trial
Amanda Baker et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2010)
Twenty-five year mortality of a community cohort with schizophrenia
Steve Brown et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Confidence intervals for random effects meta-analysis and robustness to publication bias
Masayuki Henmi et al.
STATISTICS IN MEDICINE (2010)
Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder
Jill M. Williams et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2010)
Smoking and mental illness: results from population surveys in Australia and the United States
David Lawrence et al.
BMC PUBLIC HEALTH (2009)
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia
Tony P. George et al.
BIOLOGICAL PSYCHIATRY (2008)
Factors associated with successful smoking cessation in the United States, 2000
Chung-won Lee et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2007)
A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia
A. Eden Evins et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Motivation to quit using cigarettes: A review
KD McCaul et al.
ADDICTIVE BEHAVIORS (2006)
Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect
JM Williams et al.
SCHIZOPHRENIA RESEARCH (2005)
A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia
AE Evins et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
The English smoking treatment services: one-year outcomes
J Ferguson et al.
ADDICTION (2005)
Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls
JE Strand et al.
EUROPEAN PSYCHIATRY (2005)
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia
TP George et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Characteristics of participants who stop smoking and sustain abstinence for 1 and 5 years in the lung health study
RP Murray et al.
PREVENTIVE MEDICINE (2000)
Share Paper
